Insulin receptorT1160 phosphorylation mediates renal cortical insulin resistance but not excess gluconeogenesis from glycerol
Impaired suppression of endogenous glucose production (EGP) drives end-organ damage in insulin resistance and type 2 diabetes. Although the liver is traditionally thought to mediate dysregulated EGP, the role of the renal cortex is less understood. Here, we investigate if high-fat diet (HFD) induces renal cortical insulin resistance while assessing renal glucose production (RGP) and mitochondrial metabolism in male mice. HFD increases plasma membrane sn−1,2-DAGs, PKCε translocation, and Insulin Receptor Kinase (IRK)T1160 phosphorylation while blunting insulin-stimulated pyruvate oxidation and insulin signaling. In HFD mice, RGP is elevated 6.5-fold and accounts for 60% of EGP during hyperinsulinemia. Excess RGP is derived equally from glycerol and mitochondrial sources, chiefly pyruvate. Signaling and flux defects are abrogated in HFD-fed IRKT1150A knockin mice, except for glycerol-derived gluconeogenesis. Our findings implicate the sn−1,2-DAG → PKCε → IRKT1160 axis in renal cortical insulin resistance and highlight renal gluconeogenesis as a driver of dysregulated glucose homeostasis. Here the authors report that a high fat diet causes renal cortical insulin resistance via insulin receptor T1160 phosphorylation. They also identify elevated renal gluconeogenesis as a potential driver of dysregulated whole-body glucose homeostasis.
Authors
- D Zhang
- Traci E. LaMoia (ORCID: https://orcid.org/0000-0002-8376-2240)
- Mario Kahn
- Gerald I. Shulman (ORCID: https://orcid.org/0000-0003-1529-5668)
- Ali Nasiri (ORCID: https://orcid.org/0000-0002-5190-1795)
- Sylvie Dufour (ORCID: https://orcid.org/0000-0002-0402-5403)
- Brandon T. Hubbard (ORCID: https://orcid.org/0000-0003-1957-4752)
- Yumin Ma
- Rafael C. Gaspar
Institutions
- Howard Hughes Medical Institute (US)
- Yale University (US)
Publication Details
- Journal
- Nature Communications
- Published
- 2026-05-21
- DOI
- https://doi.org/10.1038/s41467-026-73016-0
- Primary Topic
- Metabolism, Diabetes, and Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Novo Nordisk
- Novo Nordisk Fonden
- National Institutes of Health
- U.S. Public Health Service
- National Institute of General Medical Sciences
- National Institute of Diabetes and Digestive and Kidney Diseases